Epidemiology and natural history of hepatitis B infection;Épidémiologie et histoire naturelle de l'hépatite B

Revue du Praticien

Volumn 55, Issue 6, 2005, Pages 599-606

  Pol, Stanislas ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ALCOHOL CONSUMPTION; CHRONIC HEPATITIS; DEVELOPING COUNTRY; DISEASE COURSE; FRANCE; GENETIC POLYMORPHISM; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; PORTAL HYPERTENSION; REVIEW; SEXUAL TRANSMISSION; SUPERINFECTION; VACCINATION; VIRUS CELL INTERACTION; VIRUS DNA CELL DNA INTERACTION; VIRUS MUTATION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION; ACUTE DISEASE; DISEASE TRANSMISSION; LIVER TUMOR; VIROLOGY;

ACUTE DISEASE; CARCINOMA, HEPATOCELLULAR; FRANCE; HEPATITIS B; HUMANS; IMMUNOCOMPROMISED HOST; LIVER CIRRHOSIS; LIVER NEOPLASMS;

EID: 17444431517     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Wright TL, Lau JYN. Clinical aspects of hepatitis B virus infection. Lancet 1993; 342: 1340-4.
2. Bréchot C, Hadchouel M, Scotto J et al. Detection of hepatitis B virus DNA in liver and serum: a direct appraisal of the chronic carrier state. Lancet 1981; ii: 765-7.
3. Mc Mahon BJ, Alward LM, Hall DB et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599-603.
4. Krugman S, Overby LR, Mushahwar IK, Ling CM, Frösner GG, Deinhardt F. Viral hepatitis type B: studies on natural history and prevention re-examined. N Engl J Med 1979; 300: 101-6.
5. Saracco G, Macagno S, Rosina F, Rizzetto M. Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiology and clinical survey. Ann Intern Med 1988; 108: 380-3.
6. Bernuau J, Goudeau A, Poynard T et el. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6: 648-51.
7. Horney JT, Galambos JT. The liver during and after fulminant hepatitis. Gastroenterology 1977; 73: 639-45.
8. Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987; 92: 1844-50.
9. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994; 344: 1194-5.
10. Ferrari C, Penna A, Bertoletti A et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990; 145: 3442-9.
11. Penna A, Del Prete G, Cavalli A et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 1997; 25: 1022-6.
12. Bortolotti F, Cadrobbi P, Crivellaro C et al. Long-term outcoume of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 1990; 99: 805-10.
13. Zylberberg H, Pol S. Doit-on surveiller les « porteurs sains » de l'antigène HBs? Gastroenterol Clin Biol 1996; 20: 727-9.
14. Lok, AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000- summary of a workshop. Gastroenterology 2001; 120: 1828-53.
15. Gerken G, Paterlini P, Manns M et al. Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre-S and S-encoded viral surface antigens. Hepatology 1991; 13: 158-66.
16. Villeneuve JP, Desrochers M, Infante-Rivard L, Willems B, Raymond G, Bourcier M. A long-term follow-up study of asymptomatic hepatitis 8 surface antigen-positive carriers in Montreal. Gastroenterology 1994; 106: 1000-5.
17. De Franchis R, Meucci G, Vecchi M et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 1993; 118: 191-4.
18. Myers RP, Tainturier HH, Ratziu Y et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol. 2003; 39: 222-30.
19. Sakuma K, Saitoh N, Kaisa M et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study. Hepatology 1988; 8: s1642-6.
20. Chu CM, Karayiannis P, Fowler MJF, Monjardino J, Liaw YF, Thomas HC. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 1985; 5: 431-4.
21. Realdi G, Alberti A, Rugge M et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980; 79: 195-9.
22. Loriot MA, Marcellin P, Bismuth E et al. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B. Hepatology 1992; 15: 32-6.
23. Niederau K, Heintges T, Lange S et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996; 334: 1422-7.
24. Adachi H, Kaneko S, Matsusnita E, Inagaki Y, Unoura H, Kobayasni K. Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology 1992; 16: 1334-7.
25. Hoofnagle JH, Dusneiko GM, Snafer DF et el. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96: 447-9.
26. Lau JYN, Bain VG, Davies SE et al. High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992; 102: 956-62.
27. Weisberg JI, Address LL, Smith CI et al. Survival in chronic hepatitis B. Ann Intern med 1984; 101: 613-6.
28. Fattovitch G, Brollo L, Giustina G et al. Natural history and prognostic factors for chronic hepatitis B. Gut 1991; 32: 294-8.
29. Beasley RP, Lin CC, Hwang LY, Chien CS. Hepatocellular carcinoma and hepatitis 8 virus: a prospective study of 22707 men in Taiwan. Lancet 1981; ii: 1129-33.
30. McMahon BJ, Heyward WL, Templin DW, Clement D, Lanier AP. Hepatitis B-associated polyarteritis nodosa in Alaskan eskimos: clinical and epidemiologic features and long term follow-up. Hepatology 1989; 9: 97-101.